Poland · Delayed Price · Currency is PLN Medcamp Statistics
Total Valuation
Medcamp has a market cap or net worth of PLN 23.01 million. The enterprise value is 21.81 million.
| Market Cap | 23.01M |
| Enterprise Value | 21.81M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Medcamp has 26.15 million shares outstanding.
| Current Share Class | 26.15M |
| Shares Outstanding | 26.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.95% |
| Owned by Institutions (%) | n/a |
| Float | 15.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 23.41 |
| P/TBV Ratio | 23.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.75 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.97 |
| Quick Ratio | 3.97 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.96 |
Financial Efficiency
Return on equity (ROE) is -124.36% and return on invested capital (ROIC) is -5.02%.
| Return on Equity (ROE) | -124.36% |
| Return on Assets (ROA) | -4.39% |
| Return on Invested Capital (ROIC) | -5.02% |
| Return on Capital Employed (ROCE) | -22.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medcamp has paid 128,523 in taxes.
| Income Tax | 128,523 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +74.60% in the last 52 weeks. The beta is 0.11, so Medcamp's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | +74.60% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 56.42 |
| Average Volume (20 Days) | 14,509 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -330 |
| Operating Income | -221,945 |
| Pretax Income | -3.10M |
| Net Income | -3.23M |
| EBITDA | n/a |
| EBIT | -221,945 |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 1.27 million in cash and 65,574 in debt, giving a net cash position of 1.20 million or 0.05 per share.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 65,574 |
| Net Cash | 1.20M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 982,954 |
| Book Value Per Share | 0.04 |
| Working Capital | 982,957 |
Cash Flow
| Operating Cash Flow | -331,585 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Medcamp does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -14.05% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |